GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Liabilities-to-Assets

Labiana Health (XMAD:LAB) Liabilities-to-Assets : 0.89 (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Labiana Health's Total Liabilities for the quarter that ended in Dec. 2022 was €53.87 Mil. Labiana Health's Total Assets for the quarter that ended in Dec. 2022 was €60.78 Mil. Therefore, Labiana Health's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2022 was 0.89.


Labiana Health Liabilities-to-Assets Historical Data

The historical data trend for Labiana Health's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Liabilities-to-Assets Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Liabilities-to-Assets
0.78 0.83 0.89

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Liabilities-to-Assets 0.78 0.83 0.80 0.89

Competitive Comparison of Labiana Health's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Labiana Health's Liabilities-to-Assets falls into.



Labiana Health Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Labiana Health's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Liabilities-to-Assets (A: Dec. 2022 )=Total Liabilities/Total Assets
=53.873/60.779
=0.89

Labiana Health's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2022 is calculated as

Liabilities-to-Assets (Q: Dec. 2022 )=Total Liabilities/Total Assets
=53.873/60.779
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labiana Health  (XMAD:LAB) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Labiana Health Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Labiana Health's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.